210 related articles for article (PubMed ID: 3347042)
1. Estrogen and antiestrogen interaction with estrogen receptor of MCF-7 cells--relationship between processing and estrogenicity.
Gyling M; Leclercq G
J Steroid Biochem; 1988 Jan; 29(1):1-8. PubMed ID: 3347042
[TBL] [Abstract][Full Text] [Related]
2. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
3. Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells.
Borrás M; Laios I; el Khissiin A; Seo HS; Lempereur F; Legros N; Leclercq G
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):203-13. PubMed ID: 8645630
[TBL] [Abstract][Full Text] [Related]
4. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.
Tate AC; Greene GL; DeSombre ER; Jensen EV; Jordan VC
Cancer Res; 1984 Mar; 44(3):1012-8. PubMed ID: 6692388
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
Borgna JL; Scali J
J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
[TBL] [Abstract][Full Text] [Related]
6. Competitive binding assay for estrogen receptor in monolayer culture: measure of receptor activation potency.
Stoessel S; Leclercq G
J Steroid Biochem; 1986 Nov; 25(5A):677-82. PubMed ID: 2432356
[TBL] [Abstract][Full Text] [Related]
7. Exchange of bound estrogens and antiestrogens in MCF-7 cells: evidence for ligand-induced stable configurations of the estrogen receptor.
El khissiin A; Leclercq G
Steroids; 1998 Nov; 63(11):565-74. PubMed ID: 9830682
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.
Poulin R; Merand Y; Poirier D; Levesque C; Dufour JM; Labrie F
Breast Cancer Res Treat; 1989 Oct; 14(1):65-76. PubMed ID: 2605344
[TBL] [Abstract][Full Text] [Related]
9. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
Borgna JL; Scali J
Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
[TBL] [Abstract][Full Text] [Related]
10. The pure antiestrogen ICI 182,780 binds to a high-affinity site distinct from the estrogen receptor.
Parisot JP; Hu XF; Sutherland RL; Wakeling A; Zalcberg JR; DeLuise M
Int J Cancer; 1995 Aug; 62(4):480-4. PubMed ID: 7635575
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of the dextran-coated charcoal assay for estradiol receptor in breast cancer preparations.
Shafie S; Brooks SC
J Lab Clin Med; 1979 Nov; 94(5):784-98. PubMed ID: 501205
[TBL] [Abstract][Full Text] [Related]
12. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
[TBL] [Abstract][Full Text] [Related]
13. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells.
Weaver CA; Springer PA; Katzenellenbogen BS
Mol Endocrinol; 1988 Oct; 2(10):936-45. PubMed ID: 2460749
[TBL] [Abstract][Full Text] [Related]
14. Protein synthesis is not implicated in the ligand-dependent activation of the estrogen receptor in MCF-7 cells.
El Khissiin A; Cleeren A; Borràs M; Leclercq G
J Steroid Biochem Mol Biol; 1997 Jul; 62(4):269-76. PubMed ID: 9408080
[TBL] [Abstract][Full Text] [Related]
15. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
16. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
17. Estrogenic and antiestrogenic down-regulation of estrogen receptor levels: evidence for two different mechanisms.
Gyling M; Leclercq G; Heuson JC
J Recept Res; 1990; 10(5-6):217-34. PubMed ID: 2079700
[TBL] [Abstract][Full Text] [Related]
18. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
19. Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding site.
Berthois Y; Pons M; Dussert C; Crastes de Paulet A; Martin PM
Mol Cell Endocrinol; 1994 Mar; 99(2):259-68. PubMed ID: 8206333
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical and genetic evidence for specific antiestrogen binding sites.
Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
